全文获取类型
收费全文 | 696篇 |
免费 | 26篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 11篇 |
妇产科学 | 22篇 |
基础医学 | 107篇 |
口腔科学 | 3篇 |
临床医学 | 48篇 |
内科学 | 152篇 |
皮肤病学 | 7篇 |
神经病学 | 115篇 |
特种医学 | 97篇 |
外科学 | 37篇 |
综合类 | 22篇 |
预防医学 | 27篇 |
眼科学 | 9篇 |
药学 | 31篇 |
中国医学 | 5篇 |
肿瘤学 | 32篇 |
出版年
2022年 | 9篇 |
2021年 | 3篇 |
2020年 | 5篇 |
2019年 | 4篇 |
2018年 | 6篇 |
2017年 | 8篇 |
2016年 | 3篇 |
2015年 | 8篇 |
2014年 | 6篇 |
2013年 | 22篇 |
2012年 | 49篇 |
2011年 | 51篇 |
2010年 | 38篇 |
2009年 | 26篇 |
2008年 | 42篇 |
2007年 | 27篇 |
2006年 | 23篇 |
2005年 | 14篇 |
2004年 | 11篇 |
2003年 | 21篇 |
2002年 | 24篇 |
2001年 | 21篇 |
2000年 | 15篇 |
1999年 | 25篇 |
1998年 | 18篇 |
1997年 | 16篇 |
1996年 | 21篇 |
1995年 | 16篇 |
1994年 | 12篇 |
1993年 | 13篇 |
1992年 | 11篇 |
1991年 | 10篇 |
1990年 | 12篇 |
1989年 | 11篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 3篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1975年 | 5篇 |
1972年 | 5篇 |
1971年 | 3篇 |
1968年 | 4篇 |
排序方式: 共有726条查询结果,搜索用时 31 毫秒
1.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
2.
3.
4.
Normal and diseased isolated lungs: high-resolution CT 总被引:8,自引:0,他引:8
5.
6.
Coakley G; Mok CC; Hajeer AH; Ollier WE; Turner D; Sinnott PJ; Hutchinson IV; Panayi GS; Lanchbury JS 《Rheumatology (Oxford, England)》1998,37(9):988-991
OBJECTIVE: To examine whether promoter polymorphisms associated with
variation in interleukin-10 (IL-10) production are relevant to the
development of rheumatoid arthritis (RA) or Felty's syndrome (FS). METHODS:
DNA was obtained from 44 FS patients, 117 RA patients and 295 controls. The
promoter region between -533 and - 1120 was amplified by polymerase chain
reaction, and polymorphisms detected by restriction enzyme digest or
sequence-specific oligonucleotide probing. RESULTS: We found no significant
difference in allele or haplotype frequencies between the groups.
CONCLUSION: There is no association between FS or RA and these recently
identified IL-10 promoter polymorphisms. Other genetic or environmental
factors could explain the alterations in IL-10 levels seen in these
conditions.
相似文献
7.
Galeazzi M Annunziata P Sebastiani GD Bellisai F Campanella V Ferrara GB Font J Houssiau F Passiu G De Ramon Garrido E Fernandez-Nebro A Bracci L Scorza R Puddu P Jedryka-Goral A Smolen J Tincani A Carcassi C Morozzi G Marcolongo R 《The Journal of rheumatology》2000,27(1):135-141
OBJECTIVE: To assay anti-ganglioside antibodies (aGM1) in sera of a large cohort of European patients with systemic lupus erythematosus (SLE) to define the prevalence of these autoantibodies in SLE; to evaluate the association of aGM1 with clinical manifestations and other autoantibodies found in SLE; and to search for aGM1 association with HLA class II alleles. METHODS: Four hundred forty-eight patients with SLE were consecutively enrolled in 8 centers from 6 European countries. All sera were tested for antinuclear antibodies by immunofluorescence on HEp-2 cells as substrate, anti-dsDNA, aGM1, aCL, abeta2-glycoprotein I (abeta2-GPI) antibodies by ELISA, and antineutrophil cytoplasmic antibodies (ANCA) by immunofluorescence and by ELISA. Genomic typing for HLA class II loci was performed by polymerase chain reaction-sequence specific oligonucleotide probe method. Clinical assessment was done at the time of enrolment. RESULTS: We found 41.9% of patients with clinical signs of neuropsychiatric involvement; 15.5% of patients were positive for aGM1, 8% of the IgG isotype and 8.6% of the IgM isotype; aGM1-IgG were associated with neuropsychiatric manifestations (NPM) (RR = 3.7), with migraine (RR = 2.4), with OBS (RR = 7.3), and with peripheral neuropathy (RR = 8.5). aGM1-IgM were associated with NPM (RR = 4) and with depression (RR = 3.4). Furthermore, the genetic study showed that aGM1-IgG were associated with HLA-DQB1*0404 (RR = 7.2) while aGM1-IgM were associated with HLA-DQB1*0605 (RR = 33.3). No associations were found between aGM1 and anti-dsDNA, aCL, abeta2GP1, or ANCA. CONCLUSION: Our results show aGM1 can be found in patients with SLE. aGM1 may play a pathogenetic role for some NPM in this condition. 相似文献
8.
Ether lipids (EL) and hyperthermia have been shown to possess a relatively selective cytotoxicity to leukemic cells. In this study, the combined effects of EL (ET-18-OCH3, ET-16-NHCOCH3, or BM 41.440) and hyperthermia on the growth of hematopoietic progenitors, myeloid leukemic cell lines, and leukemic cells obtained from patients with acute myeloid leukemia (AML) were examined to determine if this combination resulted in a greater selective killing of leukemic cells than that achieved by either EL or heat alone. When the cells were treated simultaneously with EL (50 micrograms/mL) and hyperthermia (42 degrees C) for one hour, the killing of leukemic cell line cells was enhanced considerably. Among the three EL, however, the combination of ET-18-OCH3 and heat seemed to be the most cytotoxic to leukemic cell line cells with no effect on the growth of hematopoietic progenitors. An increase in the duration of treatment with ET-18-OCH3 to four hours with heat added during the last hour resulted in a further reduction of leukemic cell line cells while sparing 50% of hematopoietic progenitors after cryopreservation. The combined treatment with ET-18-OCH3 and heat also inhibited the growth of leukemic progenitors obtained from AML patients by 97% to 100%. These data indicate that the combined treatment with EL and hyperthermia might offer an efficient means to eliminate myeloid leukemic cells in vitro. 相似文献
9.
10.
Broen JC Bossini-Castillo L van Bon L Vonk MC Knaapen H Beretta L Rueda B Hesselstrand R Herrick A Worthington J Hunzelman N Denton CP Fonseca C Riemekasten G Kiener HP Scorza R Simeón CP Ortego-Centeno N Gonzalez-Gay MA Airò P Coenen MJ Martín J Radstake TR;Spanish Systemic Sclerosis Group 《Arthritis and rheumatism》2012,64(1):264-271